PTC Therapeutics (PTCT, $34.19) was one of top quarterly gainers, jumping +3 to $34.19 per share. A.I.dvisor analyzed 875 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.